gsk boston pharmaceuticals

News

GSK to buy liver disease drug from Boston Pharmaceuticals

GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion

The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their exclusivity periods.

PMLive · 1h

GSK to acquire Boston’s liver disease candidate efimosfermin in deal worth up to $2bn

PharmExec · 20h

GSK Acquires Boston Pharmaceuticals’ Novel FGF21 Analog for Steatotic Liver Disease

Pharmabiz8h

GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD

GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD: London, UK Thursday, May 15, 2025, ...

1don MSN

GSK to buy efimosfermin for up to $2 billion

British pharmaceutical giant GSK on Wednesday said it will buy efimosfermin, a phase III-ready potential specialty medicine ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

GSK to buy liver disease drug from Boston Pharmaceuticals

Trending now